\-\ Texto\\:\\ \ \(0\)\
\-\ sensorineural\\ hearing\\ loss\ \(17\)\
\-\ the\\ type\\ of\\ treatment\\ that\\ will\\ be\\ offered\\ to\\ the\\ patient\\ will\\ depend\\ on\\ the\\ extent\\ of\\ involvement\\ of\\ the\\ mass\\ and\\ the\\ amount\\ of\\ snhl\\ present\\.\ \(0\)\
\-\ translabyrinthine\\ resection\\ will\\ be\\ done\\ if\\ no\\ hearing\\ preservation\\ is\\ possible\\.\ \(0\)\
\-\ middle\\ cranial\\ fossa\\ approach\\ for\\ intracanalicular\\ vs\\,\\ especially\\ if\\ the\\ mass\\ is\\ laterally\\ located\\ in\\ the\\ iac\\,\\ is\\ used\\.\\ \ \(0\)\
\-\ radiation\\ therapy\\ may\\ be\\ offered\\ when\\ medical\\ contraindications\\ to\\ surgery\\ are\\ present\\ or\\ residual\\ post\\-operative\\ vs\\ remains\\.\\ it\\ is\\ given\\ to\\ patients\\ in\\ the\\ following\\ manner\\:\\ gamma\\ knife\\,\\ implying\\ low\\ dose\\,\\ sharply\\ collimated\\,\\ focused\\ cobalt\\-60\\.\ \(0\)\
\-\ an\\ avidly\\ enhancing\\ cylindrical\\ or\\ ice\\ cream\\ on\\ cone\\ cpa\\-iac\\ mass\\ is\\ seen\\.\\ the\\ mass\\ looks\\ ovoid\\ to\\ cylindrical\\.\ \(0\)\
\-\ the\\ lesion\\ is\\ small\\ \\(2\\-10mm\\)\\ lies\\ within\\ the\\ internal\\ auditory\\ canal\\,\\ looking\\ like\\ an\\ ovoid\\ to\\ cylindrical\\ mass\\.\\ \ \(0\)\
\-\ on\\ t1\\ weighted\\ imaging\\ plus\\ contrast\\,\\ there\\ is\\ a\\ focal\\ enhancing\\ mass\\ of\\ cpa\\-iac\\ cistern\\ centered\\ on\\ the\\ porus\\ acousticus\\.\ \(0\)\
\-\ vestibular\\ schwannoma\ \(8\)\
\-\ \\â\\€\\¢\\ vestibular\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ facial\\ nerve\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ epidermoid\\ cyst\ \(0\)\
\-\ \\â\\€\\¢\\ arachnoid\\ cyst\ \(0\)\
\-\ \\â\\€\\¢\\ metastasis\\ and\\ lymphoma\ \(0\)\
\-\ \\â\\€\\¢\\ aneurysm\\.\ \(0\)\
\-\ 64\\ year\\ old\\ woman\\ presents\\ with\\ a\\ right\\ sided\\ tinnitus\\ and\\ hearing\\ loss\\ that\\ was\\ slowly\\ progressive\\ in\\ nature\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cylindrical\\:\\ 0\\.09800593890332711\ \(0\)\
\-\ cpa\\-iac\\:\\ 0\\.08200482254852556\ \(0\)\
\-\ hearing\\:\\ 0\\.05874904518109404\ \(0\)\
\-\ schwannoma\\:\\ 0\\.054458560998564366\ \(0\)\
\-\ offered\\:\\ 0\\.05413754558523262\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.05101907191242425\ \(0\)\
\-\ vestibular\\:\\ 0\\.0456139108701242\ \(0\)\
\-\ ovoid\\:\\ 0\\.043764135439936624\ \(0\)\
\-\ collimated\\:\\ 0\\.04100241127426278\ \(0\)\
\-\ cobalt\\-60\\:\\ 0\\.04100241127426278\ \(0\)\
\-\ 2\\-10mm\\:\\ 0\\.04100241127426278\ \(0\)\
\-\ acousticus\\:\\ 0\\.04100241127426278\ \(0\)\
\-\ will\\:\\ 0\\.03730438630296477\ \(0\)\
\-\ translabyrinthine\\:\\ 0\\.03589258667580646\ \(0\)\
\-\ porus\\:\\ 0\\.03589258667580646\ \(0\)\
\-\ mass\\:\\ 0\\.033166353682257614\ \(0\)\
\-\ snhl\\:\\ 0\\.032668646301109036\ \(0\)\
\-\ contraindications\\:\\ 0\\.032668646301109036\ \(0\)\
\-\ implying\\:\\ 0\\.032668646301109036\ \(0\)\
\-\ cream\\:\\ 0\\.032668646301109036\ \(0\)\
\-\ looks\\:\\ 0\\.03133059015017052\ \(0\)\
\-\ vs\\:\\ 0\\.031297488096751605\ \(0\)\
\-\ intracanalicular\\:\\ 0\\.03078276207735013\ \(0\)\
\-\ cone\\:\\ 0\\.03078276207735013\ \(0\)\
\-\ depend\\:\\ 0\\.028406828943554827\ \(0\)\
\-\ iac\\:\\ 0\\.0281066497754731\ \(0\)\
\-\ plus\\:\\ 0\\.0281066497754731\ \(0\)\
\-\ sensorineural\\:\\ 0\\.027824674790280383\ \(0\)\
\-\ manner\\:\\ 0\\.02706877279261631\ \(0\)\
\-\ focused\\:\\ 0\\.02706877279261631\ \(0\)\
\-\ avidly\\:\\ 0\\.02706877279261631\ \(0\)\
\-\ tinnitus\\:\\ 0\\.02684184179647942\ \(0\)\
\-\ sharply\\:\\ 0\\.02567293747889381\ \(0\)\
\-\ lies\\:\\ 0\\.02534057020455825\ \(0\)\
\-\ looking\\:\\ 0\\.025182888568857406\ \(0\)\
\-\ knife\\:\\ 0\\.025030377765029543\ \(0\)\
\-\ enhancing\\:\\ 0\\.024929800305904738\ \(0\)\
\-\ ice\\:\\ 0\\.02488270940077568\ \(0\)\
\-\ preservation\\:\\ 0\\.024465908662684114\ \(0\)\
\-\ gamma\\:\\ 0\\.02408340588018657\ \(0\)\
\-\ centered\\:\\ 0\\.023297004345098505\ \(0\)\
\-\ loss\\:\\ 0\\.023074085325287808\ \(0\)\
\-\ post\\-operative\\:\\ 0\\.022996825177016778\ \(0\)\
\-\ auditory\\:\\ 0\\.02262453351341893\ \(0\)\
\-\ laterally\\:\\ 0\\.022279845270843483\ \(0\)\
\-\ 64\\:\\ 0\\.02165876902607826\ \(0\)\
\-\ slowly\\:\\ 0\\.021586656530562142\ \(0\)\
\-\ if\\:\\ 0\\.021569706360750097\ \(0\)\
\-\ cyst\\:\\ 0\\.021361591963033513\ \(0\)\
\-\ cistern\\:\\ 0\\.021241968287986693\ \(0\)\
\-\ approach\\:\\ 0\\.02085946550548915\ \(0\)\
\-\ dose\\:\\ 0\\.020798665126106113\ \(0\)\
\-\ remains\\:\\ 0\\.02067939800697431\ \(0\)\
\-\ arachnoid\\:\\ 0\\.019970836497290503\ \(0\)\
\-\ extent\\:\\ 0\\.0197246857928517\ \(0\)\
\-\ residual\\:\\ 0\\.0197246857928517\ \(0\)\
\-\ epidermoid\\:\\ 0\\.018932959514433714\ \(0\)\
\-\ nature\\:\\ 0\\.018813180462794572\ \(0\)\
\-\ like\\:\\ 0\\.018398632649324773\ \(0\)\
\-\ be\\:\\ 0\\.018387303116426917\ \(0\)\
\-\ is\\:\\ 0\\.018307141621828275\ \(0\)\
\-\ present\\:\\ 0\\.017953569804015634\ \(0\)\
\-\ cranial\\:\\ 0\\.017282102307638603\ \(0\)\
\-\ weighted\\:\\ 0\\.017282102307638603\ \(0\)\
\-\ facial\\:\\ 0\\.017282102307638603\ \(0\)\
\-\ amount\\:\\ 0\\.01659764814793494\ \(0\)\
\-\ done\\:\\ 0\\.01647683193210582\ \(0\)\
\-\ especially\\:\\ 0\\.016359074685667264\ \(0\)\
\-\ located\\:\\ 0\\.016359074685667264\ \(0\)\
\-\ fossa\\:\\ 0\\.016199068049772693\ \(0\)\
\-\ canal\\:\\ 0\\.015790620579973078\ \(0\)\
\-\ aneurysm\\:\\ 0\\.015709019139736293\ \(0\)\
\-\ progressive\\:\\ 0\\.015709019139736293\ \(0\)\
\-\ meningioma\\:\\ 0\\.015284136448628255\ \(0\)\
\-\ used\\:\\ 0\\.015247368171850984\ \(0\)\
\-\ metastasis\\:\\ 0\\.01487789454092989\ \(0\)\
\-\ sided\\:\\ 0\\.014695472619286724\ \(0\)\
\-\ involvement\\:\\ 0\\.01456715654245496\ \(0\)\
\-\ middle\\:\\ 0\\.01453562311461599\ \(0\)\
\-\ nerve\\:\\ 0\\.014320679658080494\ \(0\)\
\-\ that\\:\\ 0\\.013730053288919287\ \(0\)\
\-\ given\\:\\ 0\\.013625183221006244\ \(0\)\
\-\ on\\:\\ 0\\.013467739764938197\ \(0\)\
\-\ type\\:\\ 0\\.01339825222486935\ \(0\)\
\-\ possible\\:\\ 0\\.013385963808763125\ \(0\)\
\-\ internal\\:\\ 0\\.013325004052924519\ \(0\)\
\-\ radiation\\:\\ 0\\.013043029067731797\ \(0\)\
\-\ t1\\:\\ 0\\.012597653656856948\ \(0\)\
\-\ resection\\:\\ 0\\.012394956537303343\ \(0\)\
\-\ medical\\:\\ 0\\.012229347907283741\ \(0\)\
\-\ when\\:\\ 0\\.011382935988911654\ \(0\)\
\-\ lymphoma\\:\\ 0\\.01135906341576505\ \(0\)\
\-\ focal\\:\\ 0\\.011351133042504196\ \(0\)\
\-\ following\\:\\ 0\\.011280361660005341\ \(0\)\
\-\ low\\:\\ 0\\.011051944431936743\ \(0\)\
\-\ an\\:\\ 0\\.010992231295671905\ \(0\)\
\-\ therapy\\:\\ 0\\.010626236261584246\ \(0\)\
\-\ patients\\:\\ 0\\.010286393485423376\ \(0\)\
\-\ to\\:\\ 0\\.009931816475418284\ \(0\)\
\-\ surgery\\:\\ 0\\.009651158438885\ \(0\)\
\-\ or\\:\\ 0\\.009316490688034489\ \(0\)\
\-\ imaging\\:\\ 0\\.009311971276537687\ \(0\)\
\-\ woman\\:\\ 0\\.009180943941808866\ \(0\)\
\-\ small\\:\\ 0\\.00915616411340055\ \(0\)\
\-\ it\\:\\ 0\\.008934178532711706\ \(0\)\
\-\ contrast\\:\\ 0\\.008896631101432118\ \(0\)\
\-\ \\,\\:\\ 0\\.008813816086609357\ \(0\)\
\-\ may\\:\\ 0\\.008717806366968018\ \(0\)\
\-\ presents\\:\\ 0\\.00811927579306012\ \(0\)\
\-\ lesion\\:\\ 0\\.008095605702327697\ \(0\)\
\-\ treatment\\:\\ 0\\.008044730044655288\ \(0\)\
\-\ seen\\:\\ 0\\.007854081930547397\ \(0\)\
\-\ the\\:\\ 0\\.007716239146248882\ \(0\)\
\-\ within\\:\\ 0\\.007582006550632937\ \(0\)\
\-\ there\\:\\ 0\\.005914956076581343\ \(0\)\
\-\ in\\:\\ 0\\.005879961350794255\ \(0\)\
\-\ are\\:\\ 0\\.0054180180117655895\ \(0\)\
\-\ \\:\\:\\ 0\\.005257092167398442\ \(0\)\
\-\ was\\:\\ 0\\.004596639638203195\ \(0\)\
\-\ year\\:\\ 0\\.004447001252432162\ \(0\)\
\-\ right\\:\\ 0\\.0041936358563275196\ \(0\)\
\-\ old\\:\\ 0\\.004069463241219789\ \(0\)\
\-\ no\\:\\ 0\\.004002065817226986\ \(0\)\
\-\ patient\\:\\ 0\\.003984148515890177\ \(0\)\
\-\ a\\:\\ 0\\.0036893004820335003\ \(0\)\
\-\ for\\:\\ 0\\.0033912006913614655\ \(0\)\
\-\ \\(\\:\\ 0\\.003359821982529584\ \(0\)\
\-\ \\)\\:\\ 0\\.003318779963317698\ \(0\)\
\-\ of\\:\\ 0\\.002709390716232289\ \(0\)\
\-\ and\\:\\ 0\\.0025117535683565366\ \(0\)\
\-\ \\.\\:\\ 0\\.0018162553352130651\ \(0\)\
\-\ with\\:\\ 0\\.0005442054701855336\ \(0\)\
